A Novel Flavonoid Composition Targets Androgen Receptor Signaling and Inhibits Prostate Cancer Growth in Preclinical Models()()

The high prevalence and long latency period of prostate cancer (PCa) provide a unique opportunity to control disease progression with dietary and nutraceutical approaches. We developed ProFine, a standardized composition of luteolin, quercetin, and kaempferol, and investigated its potential as a nut...

Descripción completa

Detalles Bibliográficos
Autores principales: Mamouni, Kenza, Zhang, Shumin, Li, Xin, Chen, Yanhua, Yang, Yang, Kim, Jaeah, Bartlett, Michael G., Coleman, Ilsa M., Nelson, Peter S., Kucuk, Omer, Wu, Daqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034581/
https://www.ncbi.nlm.nih.gov/pubmed/29981500
http://dx.doi.org/10.1016/j.neo.2018.06.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034581/
https://www.ncbi.nlm.nih.gov/pubmed/29981500
http://dx.doi.org/10.1016/j.neo.2018.06.003

Ejemplares similares